platinum has been researched along with B16 Melanoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, D; Chakravarty, S; Haque, S; Kotcherlakota, R; Kumar, JM; Mukherjee, S; Patra, CR | 1 |
| Delauter, BJ; Egorin, MJ; Eiseman, JL; Gervais, AC; Grim, A; Hamburger, DR; Joseph, E; Pluim, D; Potter, DM; Schellens, JH; Zamboni, WC; Zuhowski, EG | 1 |
| Elliott, WL; Farrell, NP; Hoeschele, JD; Kraker, AJ; Sercel, AD; Showalter, HD | 1 |
| Farrell, N; Hacker, MP; Roberts, JD | 1 |
| Hoshi, A; Maeda, M; Sasaki, T; Suga, T; Takasuka, N | 1 |
| Khokhar, AR; Perez-Soler, R; Siddik, ZH; Wright, K | 1 |
6 other study(ies) available for platinum and B16 Melanoma
| Article | Year |
|---|---|
Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma.
Topics: A549 Cells; Allografts; Animals; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Cell Cycle; Cell Survival; Chick Embryo; Doxorubicin; Drug Delivery Systems; Drug Liberation; Endocytosis; Human Umbilical Vein Endothelial Cells; Humans; Kinetics; Melanoma, Experimental; Metal Nanoparticles; Mice; Mice, Inbred C57BL; NIH 3T3 Cells; Platinum; Polyethylene Glycols; Skin Neoplasms; Tissue Distribution; Tumor Suppressor Protein p53 | 2020 |
Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Cisplatin; DNA Adducts; DNA, Neoplasm; Factor VIII; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, SCID; Microdialysis; Models, Biological; Neoplasm Proteins; Neovascularization, Pathologic; Platinum; Specific Pathogen-Free Organisms; Tissue Distribution; Xenograft Model Antitumor Assays | 2002 |
Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Colonic Neoplasms; Diamines; Drug Resistance; Humans; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Malonates; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Nude; Molecular Structure; Platinum; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
Shikimic acid complexes of platinum. Preparation, reactivity, and antitumor activity of (R,R-1,2-diaminocyclohexane) bis(shikimato) platinum(II). Evidence for a novel rearrangement involving platinum-carbon bond formation.
Topics: Animals; Antineoplastic Agents; Carbon; Chromatography, High Pressure Liquid; Cyclohexenes; Leukemia L1210; Leukemia P388; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Organoplatinum Compounds; Platinum | 1991 |
Effect of bis(bilato)-1,2-cyclohexanediammineplatinum(II) complexes on lung metastasis of B16-F10 melanoma cells in mice.
Topics: Animals; Cyclohexylamines; Injections, Intravenous; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Organoplatinum Compounds; Platinum; Solutions; Tissue Distribution | 1990 |
Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery.
Topics: Animals; Antineoplastic Agents; Cisplatin; Drug Carriers; Hepatic Artery; Infusions, Intra-Arterial; Injections, Intravenous; Liposomes; Liver Neoplasms, Experimental; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Organoplatinum Compounds; Platinum; Rabbits; Tissue Distribution | 1988 |